logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


Rexahn Pharmaceuticals (RNN) Continues to Spike on Potential Cancer Pill, Roth Upgrade

By  +Follow January 13, 2014 10:17AM
Share:
Tickers Mentioned:

Shares in Rexahn Pharmaceuticals (RNN) jumped nearly 40 percent on Monday, continuing a bull-run that has the stock up over 150 percent since Thursday and over 265 percent in the last month on a promising potential cancer treatment and the initiation of relatively bullish coverage from Roth Capital Markets analysts.

RNN’s RX-3117 Could be Alternative for Eli Lilly’s Gemzar

Driving the current growth-spurt is the announcement of the initation of Phase 1b to study the safety and efficacy of RX-3117, Rexahn’s lead drug candidate, in cancer patients with solid tumors. The hype surrounding RX-3117 is considerable given that it has to potential to function as an oral to Eli Lilly’s (LLY) Gemzar.

"The initiation of this Phase I clinical trial of RX-3117 represents an important milestone for Rexahn," said CEO Peter D. Suzdak, Ph.D. "This compound is exciting to work with, as it has a unique profile with demonstrated activity against gemcitabine-resistant human cancer cells. We were pleased to see reduced side effect liability and oral bioavailability in cancer patients in our initial exploratory Phase I clinical trial conducted in Europe, and we believe that RX-3117 may represent a significant advancement in the treatment of cancer patients with solid tumors."

Gemzar is an injectable drug that results in resistance for 1 out of 4 patients, making an alternative that functions in pill form one with considerable commercial potential.

Analyst Seems Convinced

Also helping boost shares over the past few days was the news from Thursday that Roth Capital Markets’ Joe Pantiginis had initiated coverage on the stock at a “buy” rating with a price target of $3, still nearly double the current share price even after the spike in price.

Along with the considerable potential for RX-3117, the company boasts nearly $15 million in cash as well as over $5 million in new funding, giving it enough money to carry it for two years.

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for rnn
Mark Trader
29 Mar 15 15:42:55
The last http://t.co/8hGh2pxMWQ alert popped over 400%. So sweet and free to sign up. $OGZP $VGGL $GST $RNN $YGE $EXK $REN
Mark Trader
29 Mar 15 10:40:46
The last http://t.co/8hGh2pxMWQ alert popped over 400%. So sweet and free to sign up. $OGZP $VGGL $GST $RNN $YGE $EXK $REN
Edwin Claudio
27 Mar 15 09:00:45
RT @ProVesting: $RNN: Short Interest in Rexahn Pharmaceuticals Declines By 1.3% (RNN): http://t.co/rroz3ePRMO
ProVesting
27 Mar 15 01:20:02
$RNN: Short Interest in Rexahn Pharmaceuticals Declines By 1.3% (RNN): http://t.co/rroz3ePRMO
The Legacy News
27 Mar 15 01:12:15
Short Interest in Rexahn Pharmaceuticals Declines By 1.3% $RNN http://t.co/DcKP0NRiit
Kenneth Jønck
26 Mar 15 00:13:45
$NSPR $LJPC $VBLT $RNN $VBLT Another red day. $IBB is probably going for 50MA, which is around -2.5%. Lets see when the bell rings. On watch
US Banking News
25 Mar 15 23:38:15
Rexahn Pharmaceuticals Short Interest Down 1.3% in March $RNN http://t.co/oIbQWEen0k
BreakingStocksNews
25 Mar 15 23:25:02
$RNN: Rexahn Pharmaceuticals Short Interest Down 1.3% in March (RNN): http://t.co/CvE5YWMzgZ
Sleek Money
25 Mar 15 23:20:15
Rexahn Pharmaceuticals Short Interest Down 1.3% in March $RNN http://t.co/puNgy6QXNF
Mark Trader
25 Mar 15 17:20:23
The last http://t.co/8hGh2pxMWQ alert popped over 400%. So sweet and free to sign up. $OGZP $VGGL $GST $RNN $YGE $EXK $REN
Mark Trader
25 Mar 15 12:19:10
The last http://t.co/8hGh2pgc5i alert popped over 400%. So sweet and free to sign up. $OGZP $VGGL $GST $RNN $YGE $EXK $REN
Mark Trader
24 Mar 15 19:49:09
The last http://t.co/8hGh2pgc5i alert popped over 400%. So sweet and free to sign up. $OGZP $VGGL $GST $RNN $YGE $EXK $REN
BRENT
24 Mar 15 08:45:59
$rnn we remain bullish on this stock longer term from .75
Jet Life PennyStock$
24 Mar 15 03:24:13
DollarsOnPennies: $RNN Gallery View http://t.co/nIq7WmjxNd
HotStockAlert $PKGM$
24 Mar 15 03:14:50
DollarsOnPennies: $RNN Gallery View http://t.co/dH3NWS6nbm
explodeprofits
24 Mar 15 03:14:42
DollarsOnPennies: $RNN Gallery View http://t.co/y9K0NiPCql
Capital Market Labs
23 Mar 15 22:19:02
$SIGA, $HSGX, $CYTX, $RNN, $KIN Book Value Trend Comparison http://t.co/DsUzqQUy7e https://t.co/O7J0gCDLXd
Edwin Claudio
23 Mar 15 16:04:25
$RNN is looking good http://t.co/BnBwXID8ql
::: بنــت
23 Mar 15 12:37:06
$RNN
Capital Market Labs
23 Mar 15 12:27:49
$RNN Cash from Operations Shrinking http://t.co/12Ho2OUdk1
Edwin Claudio
23 Mar 15 12:11:52
RT @SmarterAnalyst: $RNN MLV Pounds the Table on Rexahn Pharmaceuticals http://t.co/2NtBwIHC8r
Wall Street
23 Mar 15 12:09:57
http://t.co/J58EN2Hzp9 has the most reliable picks in the market. The move fast and never fail. $EOX $RNN $GALE $MONIF $SVM $LBSR
Mark Trader
23 Mar 15 11:21:03
The last http://t.co/8hGh2pxMWQ alert popped over 400%. So sweet and free to sign up. $OGZP $VGGL $GST $RNN $YGE $EXK $REN
Edwin Claudio
23 Mar 15 10:56:37
$RNN 1.25 price forecast and your going to sell at a loss?
RangersRul
23 Mar 15 09:23:03
$RNN GOOO RNNzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzz........
Mark Trader
23 Mar 15 08:05:48
The last http://t.co/8hGh2pxMWQ alert popped over 400%. So sweet and free to sign up. $OGZP $VGGL $GST $RNN $YGE $EXK $REN
WallStreet Pennies
23 Mar 15 03:43:10
DollarsOnPennies: $RNN Gallery View http://t.co/feT3yyb0ob
DayTraderChoice
23 Mar 15 03:32:13
DollarsOnPennies: $RNN Gallery View http://t.co/Khm6QSNEJS
				
				
By  +Follow January 13, 2014 10:17AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.